IV infusion therapy is not suitable for you if you are pregnant, breastfeeding, or if you have cardiovascular disease, high blood pressure, diabetes, liver or kidney diseases
Why Weight Loss Stops on GLP-1 Therapy Your body is remarkably efficient at defending its current weight through hormonal and metabolic compensation
Giladi N, Gurevich T, Djaldetti R, et al
A 2016 comparative study published in Nature Scientific Reports demonstrated that GHK-Cu produced no cytotoxicity to human keratinocytes at concentrations up to 5,800 micromolar over 72 hours and did not induce inflammatory biomarkers, unlike other copper compounds tested alongside it
Michael Madaio, nephrologist, chair emeritus of the MCG Department of Medicine and the studys co-corresponding author